Research progress in Fc-effector functions against SARS-CoV-2

Area of Science:

• Immunology
• Virology
• Vaccinology

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, has resulted in millions of deaths globally.
• Vaccination is the primary strategy for reducing SARS-CoV-2 complications and mortality.
• The precise mechanisms of vaccine-induced protection, particularly the role of specific antibody functions, remain incompletely understood.

Purpose of the Study:

• To review recent advancements in understanding Fc-effector functions in SARS-CoV-2 immunity.
• To explore the significance of Fc-effector functions in neutralizing SARS-CoV-2, including variants.
• To discuss strategies for leveraging Fc-effector functions in developing next-generation SARS-CoV-2 vaccines.

Main Methods:

• Literature review of recent scientific publications.
• Analysis of studies investigating antibody- Fc-effector interactions in SARS-CoV-2 infection.
• Synthesis of findings on vaccine-induced immune responses.

Main Results:

• Antibody-induced Fc-effector functions are increasingly recognized as critical for controlling SARS-CoV-2.
• These functions contribute to combating viral infectivity, even against antibody-evading variants.
• Harnessing Fc-effector functions offers a promising avenue for broader vaccine efficacy.

Conclusions:

• Fc-effector functions are vital components of protective immunity against SARS-CoV-2.
• Understanding and enhancing these functions can lead to more effective vaccines against current and future SARS-CoV-2 variants.
• Targeting Fc-effector functions represents a key strategy in pandemic preparedness.